Zobrazeno 1 - 10
of 267
pro vyhledávání: ''
Autor:
Danielle S. Bitterman, Udo Hoffmann, Elizabeth H. Baldini, Anju Nohria, Raymond H. Mak, Katelyn M. Atkins, Hugo J.W.L. Aerts, Tafadzwa L. Chaunzwa, David Kozono, Balaji Tamarappoo
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:1473-1479
Mean heart dose (MHD) over 10 Gy and left anterior descending (LAD) coronary artery volume (V) receiving 15 Gy (V15Gy) greater than 10% can significantly increase the risk of major adverse cardiac events (MACE) in patients with non-small cell lung ca
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:438-443
Purpose The adrenal gland is a common site of metastasis in patients with advanced cancer, but it is rarely symptomatic. A subset of patients develop a complex pain syndrome with anorexia, nausea, and poorly localized visceral pain in the back, flank
Autor:
W. Zhu, Jiancheng Li, Xiaolong Fu, Luhua Wang, Baolin Qu, Ligang Xing, Jinming Yu, Conghua Xie, Chun Han, Zhengfei Zhu, Guang Li, Qin Lin, Yaping Xu, Zhiyong Yuan, Bing Lu, Tingyi Xia, Shenglin Ma, Gang Wu, Ming Chen, You Lu, Jianhua Wang, Guangying Zhu
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:1349-1358
Purpose This study aimed to compare erlotinib (E) and etoposide/cisplatin (EP) with concurrent radiation therapy (RT) for patients with stage IIIA/B unresectable advanced non-small cell lung cancer with activating epidermal growth factor receptor mut
Autor:
Biniyam G. Demissei, William P. Levin, Amit Maity, Abigail T. Berman, Keith A. Cengel, Sheela Krishnan, Bonnie Ky, Steven J. Feigenberg, Samuel Swisher-McClure, Gary M. Freedman, John P. Plastaras, Hari K. Narayan, Amanda M. Smith
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:946-952
The effects of thoracic radiation therapy (RT) on physical functioning and quality of life (QoL) are incompletely defined. We determined the associations between thoracic RT dose volume metrics, physical activity, and QoL in patients with cancer.Part
Autor:
Sungjune Kim, Kujtim Latifi, Gretchen MacMillan, Trevor Rose, Min-Hsuan Wang, Bradford A. Perez, Theresa A. Boyle, Scott J. Antonia, Jose R. Conejo-Garcia, Ahmad M. Karimi, Austin Lannon, Tawee Tanvetyanon, Jiannong Li, Eric B. Haura, Michael Shafique, Jhanelle E. Gray, Chase Powell, Stephen A. Rosenberg, G. Daniel Grass, Michael J. Schell, Thomas J. Dilling, Ben C. Creelan, Alberto Chiappori, James Saller, Andreas Saltos
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Consolidative thoracic radiation therapy (TRT) has been shown to improve outcomes for patients with extensive stage small cell lung cancer. We hypothesized that the addition of ipilimumab (IPI) and nivolumab (NIVO) after TRT would improve out
Autor:
Shruti Jolly, Dafydd G. Thomas, Andrea M. H. Towlerton, James A. Hayman, Khaled A. Hassan, Renato G. Martins, Muneesh Tewari, Christina S. Baik, Lili Zhao, Sylvia Lee, Theodore S. Lawrence, Nithya Ramnath, Timothy L. Frankel, Jason W.D. Hearn, Angel Qin, Bernardo H. L. Goulart, Rafael Santana-Davila, Gregory P. Kalemkerian, Ramesh Rengan, Edus H. Warren, Noah A. Brown, Bryan J. Schneider
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:170-177
Purpose Preclinical data and subset analyses from immunotherapy clinical trials indicate that prior radiation therapy was associated with better progression-free survival and overall survival when combined with immune checkpoint inhibitors in patient
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 106:985-992
Purpose The standard of care in management of patients with good performance status and unresectable stage III non-small cell lung cancer (NSCLC) therapy is concurrent chemoradiation. Newer techniques such as intensity modulated radiation therapy (IM
Autor:
Laura Hughes, Nicholas Counsell, Elizabeth Miles, Yenting Ngai, Virginia Laurence, Susan Harden, David Landau, Zafar Malik, John D. Fenwick, C. Eswar, Paula Wells, William Philip M. Mayles, Laura Farrelly, Marianne Illsley, Nazia Mohammed, Andrew Bates, James Spicer, Angel Garcia-Alonso, Anne Marie Mullin, S. Vivekanandan, Angela Baker
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
Purpose The IDEAL-CRT phase 1/2 multicenter trial of isotoxically dose-escalated concurrent chemoradiation for stage II/III non-small cell lung cancer investigated two 30-fraction schedules of 5 and 6 weeks’ duration. We report toxicity, tumor resp
Autor:
Araceli Garcia-Gonzalez, Qiuling Shi, Zhongxing Liao, Charles S. Cleeland, Mona Kamal, Steven H. Lin, Xin Shelley Wang, Tito R. Mendoza, Raza H Bokhari, Joe Y. Chang, H. Lin
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose In patients with non-small cell lung cancer (NSCLC), concurrent chemoradiation therapy (CRT) exacerbates a cluster of difficult-to-manage symptoms, especially cancer-related fatigue. Minocycline is a readily available, low-cost antibiotic wit
Autor:
Shigeyuki Murayama, Kayoko Ohnishi, Takashi Ogino, Tetsuo Akimoto, Hitoshi Wada, Yoshitaka Sato, Jun-etsu Mizoe, Tomoaki Okimoto, Hideyuki Harada, Yuta Sekino, Hitoshi Ishikawa, Naoki Nakamura, Yasuhito Kikuchi, Hideyuki Sakurai, Hiromitsu Iwata, Sunao Tokumaru, Takeshi Arimura, Hiroyasu Tamamura
Publikováno v:
International journal of radiation oncology, biology, physics. 106(1):82-89
Purpose To investigate the efficacy and safety of proton beam therapy (PBT) for the treatment of stage I non-small cell lung cancer (NSCLC). Methods and Materials Six hundred sixty-nine patients with 682 tumors histologically or clinically diagnosed